Altavera NDC 63629-2343

NDC codes

FDA NDC Directory

Product NDC (as listed)63629-2343Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63629-2343Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63629-2343-1	63629234301	3 CARTON in 1 CARTON (63629-2343-1) / 1 BLISTER PACK in 1 CARTON / 1 KIT in 1 BLISTER PACKMarketed from Jan 1, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Altavera
Generic name (nonproprietary): levonorgestrel and ethinyl estradiol
Dosage form: Kit
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 079102
Marketing start: Jan 1, 2018
Listing expires: Dec 31, 2026
Identifiers: Product ID 63629-2343_bea980c0-6724-4cc5-8018-26e87a565dd0SPL ID bea980c0-6724-4cc5-8018-26e87a565dd0SPL set ID c607816d-0da9-4960-9723-69f28aa3f2f2RxCUI 238019, 748797, 748878, 1006065

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N463629234301 followed by a unit qualifier and the quantity

Package 63629-2343-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 2, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Altavera is indicated for use by females of reproductive potential to prevent pregnancy.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 079102

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 079102
Product	Strength	Form · route	Labeler	Product NDC
Altaveralevonorgestrel and ethinyl estradiol	—	Kit	Xiromed, LLC.	70700-116